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Abstract 
Objective: This article presents the results of a retrospective study of the frequency and classification of odon-
togenic tumors recorded at four centers of diagnostic pathology in Rio de Janeiro, Brazil.
Study Design: All medical records and microscopic slides of odontogenic tumor specimens for the years 1997 to 
2007 were retrieved from the files of four services of diagnostic pathology in Rio de Janeiro City. Diagnoses were 
re-evaluated and the tumors classified according to the latest (2005) World Health Organization Classification of 
Tumors. 
Results: A total of 201 odontogenic tumors were found among 15,758 oral biopsies (1.3%). The frequencies of 
these tumors at the four centers ranged from 0.5% at the National Cancer Institute to 3.3% in a private laboratory. 
Chi-square analysis revealed statistically significant differences (p<0.05) between the proportions of odontogenic 
tumors in the studied centers. Of these, 94.5% were benign and 5.5% were malignant. Keratocystic odontogenic 
tumor (32.3%) was the most frequent lesion, followed by ameloblastoma (29.8%) and odontoma (18.4%). 
Conclusions: Odontogenic tumors are uncommon in Brazil. Different pathology laboratories reported divergent 
frequencies of odontogenic tumors, which may reflect institutional specializations and the patient populations 
served.
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Introduction 
Odontogenic tumors (OT) comprise an infrequent group 
of lesions arising from the tooth-producing tissues or 
its remnants, and these range from hamartomatous or 
non-neoplastic proliferations to benign and malignant 
neoplasm with variable aggressiveness and metastatic 
potential (1,2). 
The first internationally accepted classification system 
for these tumors was published in 1971 by the World 
Health Organization (WHO), which was reviewed and 
updated in 1992 and in 2005 (2). One of the main modi-
fications found in the newest edition was the addition of 
the odontogenic keratocyst as a benign, but locally ag-
gressive epithelial odontogenic tumor, which has been 
re-named as keratocystic odontogenic tumor (KCOT). 
The knowledge of the histological features of the dif-
ferent odontogenic tumors, as well as of their clinico-
pathological features recorded in diverse populations 
worldwide are important points that may help to iden-
tify the groups at risk and possible factors associated 
to the development of these infrequent, but biologically 
complicated lesions (2).
Data from the literature show differences in the relative 
frequencies of these tumors (3-24). Several reports on 
series of OT from different countries have documented 
distinct geographic variations in tumor prevalence, with 
the main difference being the relative incidence of amel-
oblastoma and odontoma (4,5,8,10,16,19). However, the 
inclusion of the KCOT has produced an increase in the 
frequency and prevalence of OT (20). 
There is limited information in the literature about the 
prevalence of OT in Brazil (21-24). The objective of the 
present study was to establish the frequencies and types 
of OT diagnosed in four centers of diagnostic pathology 
in Brazil, using the 2005 WHO histopathological classi-
fication of tumors and to compare the results with those 
found in similar studies from other parts of the world.
Materials and Methods
The histologic material that served as the basis for this 
study was obtained from the following pathology diag-
nostic centers located in Rio de Janeiro: National Can-
cer Institute (INCA), Army Central Hospital (HCA), 
the Anatomic Pathology Service of the Antonio Pedro 
University Hospital (Federal Fluminense Universi-
ty - HUAP) and a private pathology laboratory. Case 
records of patients with OT and KCOT spanning an 11-
year period (1997-2007) were used. Inclusion criteria: 
cases diagnosed histopathologically as OT according 
to the 2005 W.H.O. Histological Classification of Tu-
mors which had clinicopathologic information. Slides 
without histopathologic criteria for definitive diagnosis 
of OT and cases without slides and paraffin-embedded 
tumor specimens were excluded. Basic clinicopatho-
logic features, including histopathology type, patient’s 
age, gender, and the tumor site, were obtained from the 
medical records. 
The research protocol was approved by the Research 
Ethics Committee of Federal Fluminense University 
(Niterói-RJ), the National Cancer Institute (RJ), and 
the Army Central Hospital (RJ) for its implementation. 
The Director of the private laboratory also authorized 
the research. 
Hematoxylin and eosin-stained slides of all the cases 
were retrieved from the laboratories for review and the 
diagnoses were re-evaluated and the tumors reclassi-
fied according to WHO (2005) criteria. The independ-
ent opinions of two examiners were compared to reach 
the final diagnosis and in cases of doubt we consulted 
another expert oral pathologist to obtain a diagnosis by 
consensus.
For the statistical analysis, commercially available soft-
ware (SPSS 10.0; SPSS Inc, Chicago, IL) was used. De-
scriptive statistics were used in a preliminary analysis 
of the relationship between baseline variables. Continu-
ous variables were categorized to facilitate data analysis 
and presentation. Gender and tumor site analyses were 
done using the binomial test. The chi-square test was 
used to investigate differences between proportions of 
independent groups. Tests were considered statistically 
significant when the p-value was <0.05.
Results
A total of 15,748 oral biopsies were registered during 
the 11-year period of this retrospective study, in which 
we found 288 cases diagnosed as OT. After applying the 
inclusion criteria and re-evaluating the hematoxylin and 
eosin-stained sections, 87 cases were excluded, leaving 
a total of 201 cases (1.3%). Of the excluded cases, 46 
were rejected because they did not satisfy the WHO 
criteria and 36 lacked slides/paraffin-embedded tumor 
specimens or data. One case of orthokeratinized odon-
togenic cyst, one keratoameloblastoma, one unclassified 
malignant odontogenic tumor and two adenomatoid 
odontogenic hamartomas (14) were excluded on the ba-
sis of the classification used.
The frequency of OT diagnosed at the four diagnostic 
centers ranged from 0.5% at the INCA to 3.3% recorded 
at the private laboratory. Chi-square analysis revealed a 
statistically significant difference (p<0.05) between the 
proportions of OT in the centers studied (χ2 = 134.592; 
d.f. = 3; p<0.0001).The distribution of oral lesions and 
OT in the four centers are shown in table 1.
Of the 201 cases of OT, 196 (97.5%) were intraosseous 
and five (2.5%) were extraosseous (2 peripheral amelob-
lastomas, 2 peripheral calcifying epithelial odontogenic 
tumor and one peripheral calcifying cystic odontogenic 
tumor). There were 190 benign (94.5%) and 11 ma-
lignant (5.5%) tumors. The most frequent lesion was 
KCOT (32.3%), followed by ameloblastoma (29.8%) 
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and odontoma (18.4%). Statistical analysis revealed no 
significant difference between the proportions of these 
three groups (p<0.05). Ameloblastic carcinoma was the 
most common malignant tumor (3.5%). The distribution 
of histological types and the relative frequencies of OT 
by centers of diagnosis are shown in table 2. 
Regarding gender and age, 57.2% of all tumors occurred in 
males and 42.8% in females. Statistical analysis revealed no 
significant difference in the distribution of OT in relation 
to gender (p-value = 0.67, binomial test). The male-female 
ratio was 1.3:1. The age of patients at diagnosis (where this 
information was available) ranged from 5 to 82 years, with 
a mean of 35 years (s.d. = 19.4 years), most often affecting 
patients in the third and fourth decades. 
The mandible (140 cases, 69.6%) was 2.7 times more 
commonly affected than the maxilla (52 cases; 25.8%), 
and this was particularly remarkable for ameloblastoma 
and KCOT (p < 0.05, binomial test). The table 3) shows 
the gender, age and site distribution of 201 odontogenic 
tumors at the four diagnostic pathology centers.
Centers  Oral lesions (n) 
Odontogenic
Tumor (%) 
Antonio Pedro University Hospital 4.429 105 (2.4%) 
Army Central Hospital 815 17 (2.1%) 
National Cancer Institute 9.411 43 (0.5%) 
Private pathology laboratory 1.093 36 (3.3%) 
Total 15.748 201 (1.27%) 
Table 1. Distribution of oral lesions and odontogenic tumors in the diagnostic pathology 
centers.
Type of Odontogenic Tumor Antonio Pedro University Hospital 
Army Central 
Hospital 
National Cancer 
Institute 
Private pathology 
Laboratory
Total
N %
BENIGN TUMORS 
Odontogenic epithelium with mature, fibrous stroma without odontogenic ectomesenchyme 
Ameloblastoma  22 5 25 8 60 29.8 
Calcifying epithelial odontogenic tumor  4    4   2.0 
Adenomatoid odontogenic tumor  1  1  2   1.0 
Keratocystic odontogenic tumor  38 4 7 16 65 32.3 
Odontogenic epithelium with odontogenic ectomesenchyme, with or without hard tissue formation 
Ameloblastic fibroma/Fibrodentinoma  1  2 1 4   2.0 
Ameloblastic fibro-odontoma  1  1  2   1.0 
Odontoma  26 8 1 2 37 18.4 
Calcifying cystic odontogenic tumor  4    4   2.0 
Dentinogenic ghost cell tumor  1    1   0.5 
Mesenchyme and/or odontogenic ectomesenchyme with or without odontogenic epithelium 
Odontogenic myxoma / myxofibroma  5                               1 3 9   4.5 
Cementoblastoma  1                1 2   1.0 
MALIGNANT TUMORS 
Odontogenic carcinomas
Ameloblastic carcinoma                3 4 7   3.5 
Primary intraosseous squamous cell carcinoma 
derived from 
keratocystic odontogenic tumor  
  1  1   0.5 
Clear cell odontogenic carcinoma  1    1   0.5 
Odontogenic sarcomas 
Ameloblastic fibrosarcoma    1  1  2 1.0 
Total 105 17 43 36 201 100 
Table 2. Distribution of 201 benign and malignant odontogenic tumors from four diagnostic pathology centers.
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Discussion
Studies of OT from several parts of the world indicate 
that knowing the frequency and basic clinical features 
of these lesions is important because they allow to know 
more precisely the expression of these lesions in the di-
verse populations, which in turn help to identify the 
groups at risk and possible factors associated to their 
development, as well as to develop more precisely dif-
ferential diagnoses (2). 
Few reports have been published in the English lan-
guage literature using the 2005 WHO classification of 
OT (12,16,18,19,20,24). For some authors (2,20), the 
inclusion of KCOT is a factor that modify the relative 
frequency of the OT and because it is a relatively com-
mon tumor of the jaws, the KCOT will occupy a prepon-
derant place in the prevalence of OT in epidemiological 
studies of this group of lesions.
The relative frequency of odontogenic tumors in the 
present study was 1.3% of all specimens recorded be-
tween January 1997 and December 2007. This figure 
is similar to what has been reported in other studies, 
as they represent less than 3% of oral and maxillofa-
cial specimens studied in North American (3,5), South 
American (7, 21-24) and Europen series (8,11). On the 
other hand, in Africa and Asia OT comprise from 3.9% 
to 9.6% of all oral lesions (9,15,16), although an Iranian 
series had a frequency of 1.9% (18).
This study confirms that benign tumors (94.5%) are the 
most frequently seen OT; however, the malignant OT 
represented 5.5% in the present series. This frequency 
of malignant tumors is only similar to those reported in 
China (6,16), but it is higher than that those published in 
most other series (3,4,5,7,10, 21-24). 
As expected, we found KCOT to be the most common 
OT (31.8%), followed by ameloblastoma (30.3%) and 
odontoma (18.4%). There were no statistically signifi-
cant differences between the ameloblastoma and KCOT 
and odontoma groups. These results are comparable 
with the corresponding data reported by other authors 
that followed the 2005 W.H.O. Histological Classifica-
tion of Tumors (16). In contrast, Jing et al. (12), Tawfik 
and Zyada (19) and Osterne et al. (24) reported amelob-
lastoma to be most frequent lesion in Chinese, Egyp-
tian and Brazilian populations, followed by KCOT and 
odontoma. In accordance with Tawfik and Zyada (19), 
these discrepancies probably result from geographic 
variation and underestimated cases of odontoma.
According to most studies, the main difference report-
ed in the literature is related to the relative frequency 
of ameloblastoma and odontoma. In China (6,12,16), 
Egypt (19), Sri Lanka (13), Brazil (21,23) and in certain 
countries of Africa (8,9), the frequency of ameloblas-
toma was higher than odontoma, in contrast to what has 
been observed in some countries of the American Con-
Type of Tumor Male Female Total 
Age (years) Site 
1-19 20-39 40-59 60-89 NS* Total 
Max
**
Mand
***
NS* Total 
Ameloblastoma  35 25 60 6 25 13 15 1 60 7 52 1 60
Calcifying epithelial odontogenic tumor  1 3 4  2 2   4  4  4
Adenomatoid odontogenic tumor   2 2 2     2 1 1  2
Keratocystic odontogenic tumor  38 27 65 11 18 21 13 2 65 12 49 4 65
Ameloblastic fibroma Fibrodentinoma  3 1 4 1    3 4 1 3  4
Ameloblastic fibro-odontoma  1 1 2 1 1    2 1 1  2
Odontoma  26 11 37 18 11 1 1 6 37 19 15 3 37
Calcifying cystic odontogenic tumor  2 2 4 3  1   4 2 2  4
Dentinogenic ghost cell tumor  1  1 1     1  1  1
Odontogenic myxoma / myxofibroma  2 7 9 3 5 1   9 5 4  9
Cementoblastoma  1 1 2 1  1   2 1 1  2
Ameloblastic carcinoma  4 3 7   4 3  7 3 3 1 7
Primary intraosseous squamous cell 
carcinoma derived from 
keratocystic odontogenic tumor  
1  1  1    1  1  1
Clear cell odontogenic carcinoma   1 1     1 1  1  1
Ameloblastic fibrosarcoma   2 2 1 1    2  2  2
Total 115 86 201 48 64 44 32 13 201 52 140 9 201
Table 3. Gender, age and site distribution of 201 odontogenic tumors of patients at four diagnostic pathology centers.
*NS, Not specified
**Max, Maxilla
***Mand, Mandible
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tinent (3,5,7,21). Jing et al. (12) and Tawfik and Zyada 
(19) considered that the low number of odontoma cases 
recorded in their study was due to the fact that these 
lesions have a limited growth, are often asymptomatic 
and diagnosed only radiographically (left untreated or 
without pathologic examination). Also, they may go 
undiagnosed in patients who do not receive regular 
dental check-ups (19). These results show that studies 
in teaching institutions and private hospitals equipped 
with orthopantomograms do not underestimate cases of 
odontomas.
Simon et al. (10) argued that the relatively high fre-
quency of odontogenic tumors in many African coun-
tries stems from unavailability of facilities for proper 
investigations of non-aggressive tumors and delayed 
diagnosis at primary centers. Thus, retrospective stud-
ies in African hospitals usually report larger numbers 
of ameloblastomas. Therefore, as has been pointed out 
in previous studies, the relatively high frequency of ma-
lignant tumors observed in this and some other studies 
may be a reflection of the types of pathology services 
surveyed (5,22). 
In relation to sociodemographic data, a higher propor-
tion of males was affected with OT and the average age 
at diagnosis was 35 years, which is in agreement with 
the results of Simon et al. (10) in Tanzania. However, 
there are some other studies that have reported differ-
ences associated with this gender and age distribution of 
OT (7,21). The majority of articles confirm the mandi-
ble as the anatomic site most frequently affected by OT, 
especially by ameloblastoma and KCOT, which agrees 
with our findings (5,17,19,22,24,25).
Our results show that the proportion of OT varied with 
respect to the total number of oral lesions recorded at the 
four institutions studied, with percentages ranging from 
0.5% to 3.3%. The private pathology laboratory identi-
fied the highest proportion of OT and INCA the lowest. 
The results of this study are in agreement with those of 
Daley et al. (3), who consider that data from a diagnostic 
biopsy service are biased in several respects.
The private laboratory showed a greater frequency of 
OT and oral lesions than the other laboratories, possi-
bly because this center is specialized in oral pathology, 
whereas INCA is the primary cancer referral center for 
Brazil, seeing a large number of patients with oral le-
sions but predominantly with malignancies such as oral 
squamous cell carcinomas. Regarding OT, HUAP had 
the greatest number of cases (n=105). This could be be-
cause this center has been an oral pathology service in a 
University Hospital for many years and offers diagnos-
tic services to the general public. A low number of cases 
of oral lesions and OT were observed at HCA. This may 
be explained by the fact that HCA is a military institu-
tion which serves a narrow population base. 
Mosqueda-Taylor et al. (5), reported the relative frequen-
cies of OT in different centers of diagnosis in Mexico, 
and their results are very similar to ours. The highest 
frequency of OT (3.7%) in their series was observed in 
a private oral pathology laboratory. Two universities in 
their study had equal values (2.5%) and the National In-
stitute of Cancerology (Mexico) reported a frequency of 
OT of 0.8%, similar to the frequency at HUAP (2.4%) 
and INCA (0.5%) seen in the present study.
Published studies regarding the frequency and type of 
OT suggest that geographical variation, deficiency in 
dental care, as well as underestimation of cases, espe-
cially of odontoma, are factors that influence the results. 
Our study shows that OT are uncommon in Brazil and 
that the frequency of these tumors vary in accordance 
with the type of diagnostic center, even within the same 
geographical region.
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